Newsroom Stories

Using Fitbits and a novel machine learning model, a multi-institutional team led by Washington University’s Chenyang Lu is ushering in the next step in personalization for treatment of depression.

Fred Ssewamala, the William E. Gordon Distinguished Professor at the Brown School, received a five-year $3.2 million grant from the National Institutes of Health to lead a study on intervention strategies for HIV treatments among Ugandan youth. The study could advance intervention science for HIV care globally.

New research led by Kiersten Ruff, a senior research scientist in the lab of Rohit Pappu at the McKelvey School of Engineering, has uncovered the rules that govern how unfolded proteins are identified — and found that exceptions to the rules may play a role in dysfunctional cells.

Research from Ryan Bogdan’s BRAIN Lab in Arts & Sciences finds signs of psychopathology persist into mid-adolescence in kids exposed to cannabis in the womb.

While water pressure has been restored in Jackson, Miss., the water is still not safe to drink and a boil order remains in effect. The ongoing issues are a result of years of neglect and of environmental racism, says Tara Rocque at the School of Law.

Chancellor Andrew D. Martin and Provost Beverly Wendland have appointed a 13-member committee to identify candidates for the position of dean of the Brown School.

Staggeringly disproportionate startup funding available to founders who are women or underrepresented minorities has inspired the next project of the Olin Brookings Commission.

Weedy rice is a closely related cousin of crop rice that aggressively competes with cultivated rice in the field. Scientists from Washington University and the University of Arkansas report that the crop pest has become widely herbicide resistant. The study highlights challenges facing U.S. rice farmers when they battle a weedy enemy that is closely related to a desirable crop plant.

In “FIELD-STATION,” a new mural for the Sam Fox School of Design & Visual Arts, Houston-based architectural practice HOME-OFFICE explores the confluence of forestry, activism and place-based research.

The world’s first nasal vaccine for COVID-19 was approved Sept. 6 in India for emergency use. The vaccine, called iNCOVACC, is based on technology licensed from Washington University and developed in collaboration with Bharat Biotech International Limited in India.